Concepedia

Karen Thomas

KT

Statistics

Publications

22

Citations

2.6K

H-Index

18

Active since

1982

Affiliations

University of California, San Francisco(Current)

University of Southampton

Leiden University Medical Center

The Ohio State University

UCB Pharma (Germany)

Karen Thomas is an author at University of California, San Francisco specializing in medicine, pharmacotherapy, and pharmacology.

Publications per year

1982–2023

22

Publications

22

AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial

Peter A. LeWitt, Ali R. Rezai, Maureen A. Leehey et al. · The Lancet Neurology · 2011 · 672 citations

Medicine, Neurology, Neuroscience +13

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 564 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +6

Predicting and evaluating response to omalizumab in patients with severe allergic asthma

Jean Bousquet, Klaus F. Rabe, Marc Humbert et al. · Respiratory Medicine · 2007 · 305 citations · Full text

Life Sciences, Immunology, Pharmacology +12

Reliability and Validity of the Tinetti Mobility Test for Individuals With Parkinson Disease

Deb Kegelmeyer, Anne Kloos, Karen Thomas et al. · Physical Therapy · 2007 · 229 citations · Full text

Medicine, Neurology, Rehabilitation Medicine +17

Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression

Brent Bluett, Daniel M. Togasaki, Dragos Mihaila et al. · JAMA · 2021 · 158 citations · Full text

Medicine, Neurology, Pharmacology +16

1–5 of 22